Lexicon Pharmaceuticals LXRX Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's preferred stock, shares authorized?
- Lexicon Pharmaceuticals (LXRX) reported preferred stock, shares authorized of $5B in Q1 2026.
- How has Lexicon Pharmaceuticals's preferred stock, shares authorized changed year-over-year?
- Lexicon Pharmaceuticals's preferred stock, shares authorized decreased by 0.0% year-over-year, from $5B to $5B.
- What is the long-term trend for Lexicon Pharmaceuticals's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's preferred stock, shares authorized has grown at a 298.1% compound annual growth rate (CAGR), from $5M to $5B.